Reactions 1704, p256 - 2 Jun 2018 Pneumonia: case report In a study, a patient [age and sex not stated] developed pneumonia following treatment with bendamustine, cytarabine, etoposide and melphalan [routes and times to reaction onset not stated; not all dosages stated], and died subsequently. The patient, who had lymphoma and underwent autologous stem cell transplantation, received treatment with bendamustine 180 mg/m on days -7 and -6, cytarabine, etoposide and melphalan. Later, the patient died due to treatment related pneumonia on day +27. Author comment: "So far in the [bendamustine, cytarabine, etoposide and melphalan] cohort. . . a single [treatment related mortality] due to pneumonia on day +27." Glover A, et al. Autologous transplantation using bendaeam conditioning; A single centre experience and comparison with a historical matched cohort using beam conditioning. British Journal of Haematology 181 (Suppl. 1): 26, Apr 2018. Available from: URL: http://doi.org/10.1111/bjh.15226 [abstract] - United Kingdom 803323263 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera